We protect sight.

UNPARALLELED SCIENCE.
DEEP GENETIC INSIGHTS.

Translating protective biology into powerful therapies.

FOCUS ON RETINAL DEGENERATION

EXPERIENCED LEADERSHIP

K. Angela Macfarlane, JD
CEO
Anne Rubin, MBA
President
Anne Fung, MD
Chief Medical Officer
Larry A. Wheeler, PhD
Chief Technical Officer
Eugene De Juan, Jr., MD
Chief Strategy Officer
Gregory S. Hageman, PhD
Chief Science Officer
Derek Welsbie, MD
SAB Co-Chair
Don Zack, MD
SAB Co-Chair
Science. Translation. Purpose.

DIVERSIFIED PIPELINE

Based on deep understanding of novel protective biologies, Perceive Bio is developing a pipeline of assets having differentiated targets using multiple therapeutic modalities.

WE SOLVE.

Exclusivity to decades of academic research elucidating two of the strongest protective biologies in retinal degeneration.

WE PROTECT.

Novel therapeutics to prevent the largest causes of irreversible blindness preparing for clinic with lead programs in dry AMD & neuroprotection.

WE BUILD.

Team with exceptional insight & highly successful track record translating science through clinical development into strategic value.

PLEASE NOTE:

  • Perceive Bio will only contact candidates for our open jobs using a legitimate company email and not via text.
  • We will never ask you for payment or any financial transaction over text, mail, or other electronic communication as part of a job opportunity.
  • Additionally, Perceive Bio will always meet with a job candidate in person in our offices prior to making a final hiring decision.
  • If you wish to check the legitimacy of a job offering, please contact us at info@perceivebio.com and if it is not legitimate, we can provide information on how to report the issue to the FBI or other proper authority.